Skip to content


Discover the Editor-in-Chief Paolo Martelletti's 2018 picks

The Editor’s picks have brought new insights on the teratogenic and neurodevelopmental foetal risk related to the use of Valproate in migraine, to debate of Medication Overuse as secondary headache or simple sequela of migraine and dichotomy between population-based studies and clinical cognitive impairment in migraine.

European Headache Federation

Featured consensus article: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Monoclonal antibodies acting on CGRP are new drugs which can be recommended for migraine prevention. 

Neuer Inhalt


  1. Content type: Review article


    Authors: Giorgio Lambru, Sarah Miller and Manjit S Matharu

Most accessed articles RSS

View all articles

Top cited papers 2015-2016

Headache disorders are third cause of disability worldwide
Steiner T.J., Birbeck G.L., Jensen R.H. et al.

Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study
Barbanti P., Grazzi L., Egeo G. et al.

Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program
Bhola R., Kinsella E., Giffin N. et al.

Headache disorders and public ill-health in India: prevalence estimates in Karnataka State
Kulkarni GB., Rao GN., Gururaj G. et al.

Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration
Dahan H., Shir Y., Velly A. et al.

Migraine and body mass index categories: a systematic review and meta-analysis of observational studies
Ornello R., Ripa P., Pistoia F. et al.

The relationship of anxiety, depression and behavioral problems with recurrent headache in late adolescence - a Young-HUNT follow-up study
Blaauw BA., Dyb G., Hagen K. et al.

Reported concepts for the treatment modalities and pain management of temporomandibular disorders
Wieckiewicz M., Boening K., Wiland P. et al.

Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: preliminary findings from a prospective observational cohort study
Kinfe TM., Pintea B., Muhammad S. et al.

The prevalence of primary headache disorders in Nepal: a nationwide population-based study
Manandhar K., Risal A., Steiner TJ. et al.

Cluster headache: a quasi-rare disorder needing a reappraisal
Martelletti P. and Mitsikostas DD.

The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey
Mbewe E., Zairemthiama P., Yeh H-H. et al.

Sleep disturbances and quality of life in Sub-Saharan African migraineurs
Morgan I., Eguia F., Gelaye B. et al.

Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
Linde M., Steiner TJ. and Chisholm D.

(Publication years 2015-2016). Data collected January 2017. Source: Web of Science)

European Headache Federation School of Advanced Studies

The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.

The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.

Editorial Office

Editor in Chief (Founding) 
Paolo Martelletti, MD, 
Department of Clinical and Molecular Medicine
Sapienza University of Rome 
Via di Grottarossa 1035 
I-00189 Rome, Italy 
Tel.: +39-06-33775111 
Fax: +39-06-33775110 

Assistant to the Editor: Valerio De Angelis 

The Greppi Award 2019

Submissions should be made to The Journal of Headache and Pain between 1 - 31 January 2019. Read more information here.

The Italian Society for the Study of Headaches (SISC) announces the competition of the Enrico Greppi Award 2019 – 21st Edition. The award will be granted to the best unpublished original paper dealing with clinical, epidemiological, genetic, pathophysiological or therapeutic aspects of headache. The prize amounts to €10,000 and is open to researchers of all nationalities. The 2019 Award is endorsed by the European Headache Federation (EHF). The winner will be invited to present the paper at the 13th European Headache Federation Congress, to be held in Athens on 30 May - 1 June 2019.

Heralding a New Era of Episodic, Chronic and Refractory Migraine Management

​​​​​​​The scientific summary from the Springer Healthcare IME symposium Heralding a New Era of Episodic, Chronic and Refractory Migraine Management at the 2018 EHF Congress, chaired by Paolo Martelletti, is available to download.

Try the quiz at the end of the report and watch interviews with the faculty as they summarise their presentation here

Aims and scope

The Journal of Headache and Pain is a peer-reviewed open access journal published under the brand SpringerOpen. It is specifically dedicated to researchers involved in all aspects of headache and related pain, including theory, methodology, clinical practice and care. The journal's scope is broad, reflecting the wide application of scientific advances to every branch of headache and related pain management. Within a multidisciplinary perspective, The Journal of Headache and Pain covers headache and related pain syndromes in the following fields: genetics, neurology, internal medicine, clinical pharmacology, child neuropediatrics, anesthesiology, rheumatology, otology, dentistry, neurotraumatology, neurosurgery, psychiatry, pain management, addiction, public health, and epidemiology.

Academic education in headache

The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.

For more information:

Master in Headache Medicine - 16th Edition
Academic Year 2018-2019

Master of Headache Disorders - 2nd Edition
Academic Years 2018-2020


Affiliated with

2017 Journal Metrics

Related reading